Navigation Links
Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week
Date:10/31/2011

NEW YORK, Oct. 31, 2011 /PRNewswire/ -- At the American Society of Nephrology's (ASN) Kidney Week 2011, Renal Research Institute, LLC (RRI) is presenting research results from studies involving dialysis treatment, patient care and outcomes. RRI is dedicated to advancing therapy options for dialysis patients to provide the highest caliber of care based on advanced clinical technology. ASN's Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, PA. It is the largest scientific gathering of kidney disease experts worldwide and organizers expect more than 13,000 attendees among them more than 10,000 scientists and clinicians.  

A selection of RRI research being presented this year includes:

  • Declining Interdialytic Weight Gain in Chronic HD Patients: An Ominous Sign? Results of an International Study. Adrian Marcos Guinsburg, MD, Cristina Marelli, MD, Adam Tashman, Michael Etter, MD, PhD, Daniele Marcelli, MD, Gero D. von Gersdorff, MD, Mathias Schaller, Yuedong Wang, PhD, Nathan W. Levin, MD, Peter Kotanko, MD and Len A. Usvyat.

  • Lower Dialysate Na+ Impacts Weight Gain And Fluid Overload Hospitalizations. Eduardo K. Lacson, MD, John Rogus, PhD, Peter Kotanko, MD, Nathan W. Levin, MD and Raymond M. Hakim, MD, PhD

  • Trends in Serum Na+ Levels Relate to Mortality in Incident HD Patients. Jochen G. Raimann, MD, Len A. Usvyat, Jeroen Kooman, MD, Frank van der Sande, MD, PhD, Stephan Thijssen, MD, Peter Kotanko, MD, Nathan W. Levin, MD.

  • Independent Validation of a Versatile Citrate Dialysis Model. Stephan Thijssen, MD, Len A. Usvyat, Jeffrey J. Sands, MD, Nathan W. Levin, MD, Peter Kotanko, MD and Jose A. Diaz-Buxo, MD

  • Red Blood Cell Life Span is Associated with Hemoglobin Variability in Chronic Hemodialysis Patients. Yanna Dou, MD, Anja Kruse, MD, Georges Ouellet, MD, Stephan Thijssen, MD, Nathan W. Levin, MD and Peter Kotanko, MD.

RRI will share their newest scientific findings in a total of over two dozen presentations at this year's ASN Kidney Week. Kidney Week 2011, the largest nephrology meeting worldwide, will provide a forum to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. RRI contributes research to ASN each year on kidney disease, its related complications and treatment options, to further the advancement of kidney care quality and patient outcomes.

Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.

About Renal Research Institute

Formed in early 1997, Renal Research Institute embodies scientific commitment to better kidney care. RRI is a research collaboration between Fresenius Medical Care and New York's Beth Israel Medical Center with a goal to produce measurable improvements in patient outcomes, building on clinical nephrology and evaluating and applying new technology to enhance the quality of patient care. Through its collaborative relationships with dialysis facilities and strong ties to academic research institutions, RRI is able to enhance the spectrum of comprehensive renal services by advancing peritoneal and hemodialysis therapies through clinical research and the application of practice guidelines and new technology. This synergy with university partners, industry, and dialysis clinics is the first of its kind in the field of kidney disease. For more information, please visit www.renalresearch.com.


'/>"/>
SOURCE Renal Research Institute, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PLC Systems RenalGuard® to be Featured in Chronic Kidney Disease and Contrast Nephropathy Session at TCT 2011
2. PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.
3. PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany
4. PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology
5. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
6. REMEDIAL II Trial of PLCs RenalGuard® Article Published in Circulation
7. Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
8. B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System
9. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
10. PLC Ramps Up for U.S. Clinical Trial of RenalGuard®
11. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):